O

Ossur hf
CSE:OSSR

Watchlist Manager
Ossur hf
CSE:OSSR
Watchlist
Price: 26.4 DKK -2.22%
Market Cap: 11.3B DKK
Have any thoughts about
Ossur hf?
Write Note

Net Margin
Ossur hf

7.1%
Current
7%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
7.1%
=
Net Income
56.9m
/
Revenue
804.3m

Net Margin Across Competitors

Country IS
Market Cap 11.3B DKK
Net Margin
7%
Country US
Market Cap 199.9B USD
Net Margin
14%
Country US
Market Cap 191.9B USD
Net Margin
29%
Country US
Market Cap 140.8B USD
Net Margin
16%
Country US
Market Cap 134.7B USD
Net Margin
11%
Country IE
Market Cap 104.7B USD
Net Margin
13%
Country US
Market Cap 65.9B USD
Net Margin
9%
Country DE
Market Cap 58.1B EUR
Net Margin
8%
Country US
Market Cap 44.8B USD
Net Margin
74%
Country CN
Market Cap 314.4B CNY
Net Margin
33%
Country US
Market Cap 36.4B USD
Net Margin
9%
No Stocks Found

Ossur hf
Glance View

Market Cap
11.3B DKK
Industry
Health Care

Össur hf. is an Icelandic company that stands as a quiet marvel in the realm of orthopedic innovation, specializing in the development of non-invasive equipment designed to enhance human mobility. Born out of a small prosthetics shop in Reykjavik in 1971, the company has grown into a global leader in orthopedic solutions. At its core, Össur's operations revolve around the invention and commercialization of cutting-edge prosthetics, braces, and supports aimed at improving the quality of life for people who face limb challenges due to injuries, disabilities, or age-related conditions. The company's ethos of "Life Without Limitations" guides its pursuit to blend medical technology and engineering in a way that restores human dignity and functionality, manifesting a unique synergy between advanced robotics and biology. Commercially, Össur thrives by leveraging its commitment to research and development, channeling substantial investment into creating high-demand products characterized by reliability, adaptability, and innovation. Revenue streams primarily flow from the sale of prosthetic limbs and associated components, together with orthopedic support products that are distributed both directly and through a network of wholesalers and medical professionals worldwide. By maintaining a diversified product line and focusing on customer-centric customization, Össur meets a significant demand within healthcare systems, insurance providers, and direct consumer markets. The company's ability to translate its scientific prowess into marketable and life-enhancing solutions has cemented its reputation as a key player in the med-tech industry, aligning financial success with a meaningful social mission.

OSSR Intrinsic Value
25.57 DKK
Overvaluation 3%
Intrinsic Value
Price
O

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
7.1%
=
Net Income
56.9m
/
Revenue
804.3m
What is the Net Margin of Ossur hf?

Based on Ossur hf's most recent financial statements, the company has Net Margin of 7.1%.